Please use this identifier to cite or link to this item: https://repository.unej.ac.id/xmlui/handle/123456789/78361
Title: Epi-croomine and croomine from Stemona tuberosa antimalarial drug for inhibiting dihydrofolate reductase (DHFR) activity and their molecular modeling
Authors: Pudjiastuti, Pratiwi
Sumarsih, Sri
Arwati, Heny
Amalina, Ilma
Fanani, Much. Z.
Utomo, Edi P.
Fitri, Loeki E.
Nugraha, Ari Satia
Lie, Wilford
Pyne, Stephen G.
Keywords: malaria
epi-croomine
croomine
DHFR
Stemonatuberosa
Issue Date: 14-Dec-2016
Abstract: One of the mechanism actions of antimalarial drugsis by an inhibiting on the enzyme dihydrofolate reductase (DHFR), an enzyme target antifolate drug. Epi-croomine and croomine , are alkaloids isolated from Stemonatuberosa showed DHFR inhibition with K i of 61.14 and 100.59 µM and K values of30.68 and 27.06 µM at 10 ppm. The IC 50 M to the DHFR of croomine and pyrimethamine were 5.29 and 7.71 µM, respectively. Tuberostemonine is not active to the enzyme. The kinetic analysis showed that both epi-croomine and croomine competitively inhibited to the human DHFR recombinant. The molecular modeling of the compounds to the human DHFR was estimate depi-croomine and croomine’s binding free energy of -6.66 and -7.60 kcal/mol. The docking showed that both epi-croomine and croomine could possibly form hydrogen bonds with the amino acid residue of theAla9, which residues on the active site of the enzyme.
URI: http://repository.unej.ac.id/handle/123456789/78361
ISSN: 0975-7384
Appears in Collections:LSP-Jurnal Ilmiah Dosen

Files in This Item:
File Description SizeFormat 
JCPR_ASN_2014_SKKD.pdf1.24 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.